OLIGOMERIX funded by the Alzheimer's Drug Discovery Foundation to evaluate compounds active against tau oligomers, a novel target for therapeutic development

New York, NY, July 7, 2008 (BUSINESS WIRE) – Oligomerix, Inc. today announced receipt of a program-related investment of $100K from the Alzheimer’s Drug Discovery Foundation (ADDF). Read more...